Cite

HARVARD Citation

    Skorska, A. et al. (2017). GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration. Stem cell research & therapy. 8 (1), pp. 1-15. [Online]. 
  
Back to record